Persico, Antonio M.
Arango, Celso
Buitelaar, Jan K.
Correll, Christoph U.
Glennon, Jeffrey C.
Hoekstra, Pieter J.
Moreno, Carmen
Vitiello, Benedetto
Vorstman, Jacob
Zuddas, Alessandro
Funding for this research was provided by:
European Community’s Seventh Framework Programme (FP7/2007-2013)
PERS (242959)
TACTICS (278948)
ADDUCE (260576)
STOP (261411)
MATRICS (603016)
AGGRESSOTYPE (602805)
EU-GEI (241909)
OPTiMISE (242114)
PSYSCAN (603196)
METSY (602478)
Innovative Medicines Initiative Joint Undertaking (115300)
European Union’s Seventh Framework Programme (FP7/2007-2013)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Italian Ministry of Health
Fondazione Gaetano e Mafalda Luce, Autism Speaks and the Autism Research Institute
Sardinian Regional Secretary of Health
Spanish Ministry of Economy and Competitiveness, Instituto de Salud Carlos III, CIBERSAM, Madrid Regional Government (S2010/BMD-2422 AGES)
European Union Structural Funds, Fundación Alicia Koplowitz and Fundación Mutua Madrileña
This article is maintained by: Elsevier
Article Title: Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
Journal Title: European Neuropsychopharmacology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.euroneuro.2015.06.009
Content Type: article
Copyright: Copyright © 2015 Elsevier B.V. and ECNP. Published by Elsevier B.V. All rights reserved.